Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin, Vincristine, Radiotherapy and Adjuvant Chemotherapy in High-Risk CNS Embryonal Tumors
NCT00003203Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Mar 1998
- Primary completion
- Oct 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of carboplatin in central nervous system embryonal tumor (2 arms), sponsored by Children's Oncology Group. Primary endpoint: Event Free Survival. Started Mar 1998; status: completed.
02
Drugs
carboplatin
03
Conditions
central nervous system embryonal tumor
Beyond the preview
Go deeper on NCT00003203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003203.